GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Institutional Ownership

BrightPath Biotherapeutics Co (TSE:4594) Institutional Ownership : 1.36% (As of Mar. 02, 2025)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BrightPath Biotherapeutics Co's institutional ownership is 1.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BrightPath Biotherapeutics Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BrightPath Biotherapeutics Co's Float Percentage Of Total Shares Outstanding is 0.00%.


BrightPath Biotherapeutics Co Institutional Ownership Historical Data

The historical data trend for BrightPath Biotherapeutics Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co Institutional Ownership Chart

BrightPath Biotherapeutics Co Historical Data

The historical data trend for BrightPath Biotherapeutics Co can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 1.75 1.75 1.75 2.20 2.20 1.88 1.39 1.36 1.36 1.36

BrightPath Biotherapeutics Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


BrightPath Biotherapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co Headlines

No Headlines